Association analysis of polymorphisms in IL-5 and IL-9, with Allergic Asthma disease in Al-Diwaniyah City., PMID:40491234
[Application and research progress of anti-IL-4α monoclonal antibody dupilumab in the treatment of type 2 asthma]., PMID:40491151
Adaptive immune changes in colorectal cancer: a focus on T and B cell activation genes., PMID:40484866
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4-Dinitrochlorobenzene-Induced Mouse Model of Atopic Dermatitis., PMID:40484710
Two unique cases of eosinophilic granulomatosis with polyangiitis in childhood treated with anti-interleukin-5 therapy: infantile-onset and submandibular salivary gland involvement., PMID:40457436
Suppression of Il5 and Il13 Gene Expression by Synthetic siRNA Molecules Reduces Nasal Hyperreactivity and Inflammation in a Murine Model of Allergic Rhinitis., PMID:40451198
Differences in Aqueous Humor Cytokine Concentrations According to the Presence of Posterior Subcapsular Cataract: A Prospective Case-Control Study., PMID:40441712
Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens., PMID:40436912
How to adjust asthma management once asthma is controlled on long term biologic therapy., PMID:40436142
Long-term safety and effectiveness of mepolizumab for patients with bronchial asthma in routine clinical practice in Japan - final report of special drug use investigation., PMID:40398189
Systemic secukinumab treatment in patients with ankylosing spondylitis: the relationship between systemic and tear proinflammatory cytokines and ocular surface findings-a pilot study., PMID:40394377
Vaccination against helminth IL-33 modulators permits immune-mediated parasite ejection., PMID:40378045
Drug evaluation: mepolizumab in chronic obstructive pulmonary disease., PMID:40366762
Relation of Cytokine Profile and Antibody Values to Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis (Preliminary Data)., PMID:40353964
Depemokimab in chronic rhinosinusitis with nasal polyps: A turning point or a missed opportunity?, PMID:40347936
High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor., PMID:40345261
Inhibitory Effects of Phellodendri Cortex Against Airway Inflammation and Hyperresponsiveness in Ovalbumin-Induced Murine Asthma Model., PMID:40333800
Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren's syndrome: a cross-sectional study., PMID:40329232
Puriton attenuates the asthma severity in ovalbumin-induced murine model via balancing Th1/Th2 and inhibiting inflammation., PMID:40323927
Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies., PMID:40305320
Improving patient outcomes: Mepolizumab's impact in IL-5-mediated diseases., PMID:40296395
Challenges and Opportunities in Achieving Asthma Remission., PMID:40283665
Topical Application of Fluoxetine Improves DNCB-Induced Atopic Dermatitis in Mice., PMID:40243303
A Randomized, Controlled Study Evaluating Effects of Saccharomyces boulardii in Adult Patients with Asthma., PMID:40228543
Tyramide signal amplification for a highly sensitive multiplex immunoassay based on encoded hydrogel microparticles., PMID:40208772
Benralizumab and the integrated management of co-morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps., PMID:40200389
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes]., PMID:40198352
Effect of anti-interleukin-5 antibody on development of vasculitis in an ovalbumin-induced eosinophilic vasculitis mouse model., PMID:40176907
IgE-Mediated Activation of Mast Cells and Basophils in Health and Disease., PMID:40165512
Head-To-Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?, PMID:40156481
A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months., PMID:40151546
Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)., PMID:40127967
Enhanced Humoral and Cellular Immune Responses Elicited by Salmonella Flagellin-Adjuvanted SARS-CoV-2 S1 Subunit Vaccine., PMID:40127244
Treatment and Monitoring of Eosinophilic Fasciitis., PMID:40115529
Type 2 inflammation, a common denominator in chronic airway disease?, PMID:40104899
The RNA-binding protein KSRP reduces asthma-like characteristics in a murine model., PMID:40095032
Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis., PMID:40088970
Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome., PMID:40071429
Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis., PMID:40060399
[Guidelines for the prevention and management of bronchial asthma (2024 edition)]., PMID:40050074
Asthma Phenotypes and Biomarkers., PMID:40013975
Results of personalized biological therapy in patients with chronic rhinosinusitis with nasal polyps and severe uncontrolled bronchial asthma - real-life study., PMID:40008473
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives., PMID:40004611
Guidance for type 2 inflammatory biomarkers., PMID:39978136
Immune response and leukocyte profile in patients infested with Sarcoptes scabiei in Duhok Province of Kurdistan region, Iraq., PMID:39977480
Evaluation of Rhinological Symptoms and Quality of Life in Patients with Allergic or Eosinophilic Severe Uncontrolled Asthma Treated with Anti-IgE or Anti-IL5 Therapy: A Real-Live Study., PMID:39970894
Type 2 immunity in allergic diseases., PMID:39962262
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis., PMID:39960116
Tezepelumab for the treatment of chronic spontaneous urticaria: Results of the phase 2b INCEPTION study., PMID:39956278
Elevated Type 2 Inflammatory Factors, Th2/Th1 Balanced Status, and Exosomes as a Marker of Severity in Chronic Actinic Dermatitis., PMID:39949921
For research use only. Not for human or drug use.
